Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE697.6553.7 (+8.34 %)
PREV CLOSE ( ) 643.95
OPEN PRICE ( ) 658.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7785
TODAY'S LOW / HIGH ( )631.05 708.30
52 WK LOW / HIGH ( )247.3 708.3
NSE698.5553.65 (+8.32 %)
PREV CLOSE( ) 644.90
OPEN PRICE ( ) 648.45
BID PRICE (QTY) 698.55 (7597)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 163153
TODAY'S LOW / HIGH( ) 628.70 709.35
52 WK LOW / HIGH ( )245.75 709.35
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Rama Mohan Rao - Managing Director
Registered Office

Address Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-30211600

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

08May Reliance Industries, Neuland Laborator
Vista Equity Partners (Vista) will invest Rs 11,367 crore into Reliance..
08May Neuland Laboratories receives EIR from
Neuland Laboratories has received Establishment Inspection Report (EIR)..
08May Neuland Laboratories jumps on receivin
Neuland Laboratories is currently trading at Rs. 437.00, up by 19.55 poi..
23Apr Neuland Laboratories submits RTA certi
Neuland Laboratories has informed about submission of certificate as req..
10Feb Neuland Laboratories gets two observat
The United States Food and Drug Administration (USFDA) has inspected one..

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit-93.5099999999999158.81
Gross Profit 170.76 524.97
Operating Profit 317.71053.44
Net Sales 1918.667627.11

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15544.55 (2.18%)
M.Cap ( in Cr)33031.08
Ipca Laboratories (BSE)
peergroup  1777.15 (7.64%)
M.Cap ( in Cr)22454.67
Dr. Reddys Lab (BSE)
peergroup  4150.85 (2.79%)
M.Cap ( in Cr)69000.62
Astrazeneca Pharma I (BSE)
peergroup  3347.95 (1.97%)
M.Cap ( in Cr)8369.88
Ajanta Pharma (BSE)
peergroup  1409.50 (4.33%)
M.Cap ( in Cr)12299.48

Shareholding Pattern

MUTUAL FUNDS/UTI 4.15%
PROMOTERS 36.27%
NON-INSTITUTION 34.12%
FI/BANKS/INSURANCE 0.2%
GOVERNMENT 0%
FII 0%

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 643.95. Its current market capitalisation stands at Rs 895.08 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7627.11 Cr and Total Income of Rs.7665.97 Cr. The company's management includes Christopher M Cimarusti, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, William Gordon Mitchell, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are KS Aiyar & Co, MSKA & Associates, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)